Pittsburgh, PA, United States
Pittsburgh, PA, United States

Time filter

Source Type

WiseGuyReports.Com Publish a New Market Research Report On –“Medical Disposables Industry Global Production,Growth,Share,Demand and Applications Market Research Report to 2022”. According to Researcher, the Global Medical Disposables Market is accounted for $178.37 billion in 2015 and is expected to reach $267.96 billion by 2022 growing at a CAGR of 5.9%. In the present scenario healthcare advancement in techniques and new care products are hovering over the market. Rising geriatric population and more occurrence of chronic disease which need utmost care in hospitals are the reasons behind the growth of the market. Moreover stringent FDA and GMP approval norms which reduce the infection case are going to curb the market. For more information or any query mail at [email protected] Hospital segment among the end-users is anticipated to grow at exponential pace led by the rising admissions in hospitals owing to more no: of patients. Moreover medical disposables in product segment are expected to grow at a strong pace because of more people visiting hospitals for regular checkups, surgeries and patient admissions. North America is estimated to be the largest market, as it inherited advanced healthcare very early and Asia Pacific is expected to grow at a rapid pace because of recent advancements in healthcare and more amount of aging population. Some of the Key players of the market are B. Braun Melsungen AG, Halyard Health Incorporated, Domtar Corporation, Roche Diagnostics Corporation, Abbott Diabetes Care Inc.,, Bayer Healthcare AG, Johnson & Johnson, 3M Company, Smith & Nephew plc , SCHOTT AG, Ahlstrom Corporation , Becton Dickinson, and Company, Terumo Corporation, Kimberly-Clark Corporation, Medtronic plc, STERIS Corporation, Baxter International Incorporated, Halyard Health Incorporated and Covidien Plc. Products Covered:  • Wound Management Disposables  o Disposable Bandages  § Cast Bandages & Accessories  § Pads & Compresses  § Adhesive Bandages  § Gauze Bandages  § Adhesive Tapes  § Other Disposable Bandages  o Wound Dressings  § Non-Adherent Wound Dressings  Ø Contact Layers  Ø Gauze Wound Dressings  § Biological & Synthetic Wound Dressings  Ø Collagen Dressings  Ø Hydrogel Dressings  Ø Film Dressings  Ø Alginate Dressings  Ø Hydrocolloid Dressings  Ø Foam Dressings  Ø Other Biological & Synthetic Wound Dressings  o Wound Closures  § Tissue Sealants  Ø Fibrin  Ø Cyanoacrylates  Ø Other Tissue Sealants  § Sutures  Ø Absorbable Sutures  Ø Nonabsorbable Sutures  § Surgical Staples & Disposable Stapling Devices  § Other Wound Closures  Ø Ligature Clips  Ø Anti-Adhesion  Ø Suture Accessories  Ø Hemostats  o Other Disposable Wound Management  § Medical Sponges  § First Aid Kits  § Medical Cotton Goods  • Drug Delivery Disposables  o Disposable Hypodermic  § Clinical Hypodermic Syringes  § Prefillable Syringes  Ø Cartridge Devices  Ø Injectors  § Clinical Hypodermic Needles  o Disposable Dialysis  § Disposable Peritoneal Dialysis  § Disposable Hemodialysis  o Disposable Infusion  § Premixed IV Solutions  § Disposable IV Administration Sets  § Disposable IV Catheters  § Other Disposable Infusion  Ø IV Accessories  Ø Enteral Feeding Sets  o Transdermal Patches  o Disposable Inhalation  § Anesthesia Disposables  § Prefillable Inhalers  Ø Dry Powder Inhalers  Ø Metered Dose Inhalers  § Disposable Humidifiers  § Disposable Oxygen Therapy  § Disposable Nebulizers & Accessories  § Other Inhalation Disposables  • Nonwoven Medical Disposables  o Disposable Medical Garments & Textiles  § Surgical Drapes  § Face Masks  § Surgical Gowns  § Patient Gowns  § Other Disposable Medical Garments & Textiles  Ø Towels & Bedding  Ø Staff Apparel  o Incontinence Disposables  § Adult Shields  § Incontinence Underpads  § Adult Undergarments  § Other Incontinence Disposables  • Other Products Regions Covered:  • North America  o US  o Canada  o Mexico  • Europe  o Germany  o France  o Italy  o UK  o Spain  o Rest of Europe  • Asia Pacific  o Japan  o China  o India  o Australia  o New Zealand  o Rest of Asia Pacific  • Rest of the World  o Middle East  o Brazil  o Argentina  o South Africa  o Egypt What our report offers:  - Market share assessments for the regional and country level segments  - Market share analysis of the top industry players  - Strategic recommendations for the new entrants  - Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets  - Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)  - Strategic recommendations in key business segments based on the market estimations  - Competitive landscaping mapping the key common trends  - Company profiling with detailed strategies, financials, and recent developments  - Supply chain trends mapping the latest technological advancements 1 Executive Summary  2 Preface  2.1 Abstract  2.2 Stake Holders  2.3 Research Scope  2.4 Research Methodology  2.4.1 Data Mining  2.4.2 Data Analysis  2.4.3 Data Validation  2.4.4 Research Approach  2.5 Research Sources  2.5.1 Primary Research Sources  2.5.2 Secondary Research Sources  2.5.3 Assumptions  3 Market Trend Analysis  3.1 Introduction  3.2 Drivers  3.3 Restraints  3.4 Opportunities  3.5 Threats  3.6 Product Analysis  3.7 Emerging Markets  4 Porters Five Force Analysis  4.1 Bargaining power of suppliers  4.2 Bargaining power of buyers  4.3 Threat of substitutes  4.4 Threat of new entrants  4.5 Competitive rivalry For more information or any query mail at [email protected] Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports features an exhaustive list of market research reports from hundreds of publishers worldwide. We boast a database spanning virtually every market category and an even more comprehensive collection of market research reports under these categories and sub-categories.


News Article | February 16, 2017
Site: www.PR.com

The agenda has been released and registration is now open for SMi’s Pharmaceutical Microbiology USA show. The seventh in its series, this event will take place in San Diego, on the 8th and 9th June 2017. San Diego, CA, February 16, 2017 --( Through a series of presentations from handpicked industry experts, two pre-conference workshops and an additional interactive training session, the agenda will discuss hot topics such as rapid microbiology methods (RMM), risk assessment, challenges in endotoxin recovery, environmental monitoring, sterility assurance, data integrity and much more. Chairs for 2017: - Donald Singer, GSK Fellow, Steriles Microbiology, R&D, GSK - John Duguid, Senior Director, Research & Development, Vericel Corporation Expert Speaker Line-Up: - Ron Smith, Director, External Supply Integration Quality, Janssen - Ren-Yo Forng, Scientific Director, Amgen - Kevin Luongo, QC Sr. Scientist (Microbiology), Takeda - Elizabeth Hulanick, Microbiologist, Renaissance Pharmaceuticals - Paul Ricciatti, Sterility Assurance Manager, Bimeda - Jeanne Moldenhauer, Vice President, Excellent Pharma Consulting - Akua Gilbert-Arthur, Principal Scientist, Roche Molecular Systems - Jarett Scalzo, QC, Microbiology Manager, Kite Pharma Benefits of attending: - Discuss the challenges involved with microbial control with Takeda - Following the path to efficient sterility assurance with GSK - Bimeda highlight the importance of environmental modelling - Delve into the latest developments in rapid microbial methods with Janssen - Hear the latest on data integrity and compliance with Roche - Take part in an interactive extended training session with Microrite Running alongside the conference will be two pre-conference workshops held on the 7th June. Workshop A: Technologies for Monitoring Contamination Control and Case Studies on Contamination Control. Hosted by Jim Polarine Jr, Senior Technical Service Manager, STERIS Corporation and Andrew Bartko, Research Leader, Battelle Memorial Institute. Workshop B: Microbial Required Use for Terminal Sterilization. Hosted by Jerry Dalfors, Principal, JD Technologies For those wanting to attend, there is currently an early bird offer available; book by 28th February to save $300 off the conference price. Register at www.pharma-microbiology-usa.com/prcom Pharmaceutical Microbiology USA is sponsored by Charles River and Rapid Microbiosytems For sponsorship packages: Contact Alia Malick +44 (0) 207 827 6168 or e-mail amalick@smi-online.co.uk. For delegate enquiries: Contact Fateja Begum on +44 (0) 20 7827 6184 or email fbegum@smi-online.co.uk For media enquiries, contact Zoe Gale on +44 (0) 20 7827 6138 or zgale@smi-online.co.uk Pharmaceutical Microbiology USA 8 - 9 June 2017 San Diego, California, USA www.pharma-microbiology-usa.com/prcom Contact e-mail: zgale@smi-online.co.uk Contact tel: +44 (0) 207 827 6184 #smimicrobiology About SMi Group: Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world’s most forward thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk San Diego, CA, February 16, 2017 --( PR.com )-- Aimed at Microbiologists, Quality Control and Quality Assurance Managers, Pharmaceutical Microbiology USA 2017 will address the current challenges and developing trends of the pharmaceutical microbiology field.Through a series of presentations from handpicked industry experts, two pre-conference workshops and an additional interactive training session, the agenda will discuss hot topics such as rapid microbiology methods (RMM), risk assessment, challenges in endotoxin recovery, environmental monitoring, sterility assurance, data integrity and much more.Chairs for 2017:- Donald Singer, GSK Fellow, Steriles Microbiology, R&D, GSK- John Duguid, Senior Director, Research & Development, Vericel CorporationExpert Speaker Line-Up:- Ron Smith, Director, External Supply Integration Quality, Janssen- Ren-Yo Forng, Scientific Director, Amgen- Kevin Luongo, QC Sr. Scientist (Microbiology), Takeda- Elizabeth Hulanick, Microbiologist, Renaissance Pharmaceuticals- Paul Ricciatti, Sterility Assurance Manager, Bimeda- Jeanne Moldenhauer, Vice President, Excellent Pharma Consulting- Akua Gilbert-Arthur, Principal Scientist, Roche Molecular Systems- Jarett Scalzo, QC, Microbiology Manager, Kite PharmaBenefits of attending:- Discuss the challenges involved with microbial control with Takeda- Following the path to efficient sterility assurance with GSK- Bimeda highlight the importance of environmental modelling- Delve into the latest developments in rapid microbial methods with Janssen- Hear the latest on data integrity and compliance with Roche- Take part in an interactive extended training session with MicroriteRunning alongside the conference will be two pre-conference workshops held on the 7th June.Workshop A: Technologies for Monitoring Contamination Control and Case Studies on Contamination Control. Hosted by Jim Polarine Jr, Senior Technical Service Manager, STERIS Corporation and Andrew Bartko, Research Leader, Battelle Memorial Institute.Workshop B: Microbial Required Use for Terminal Sterilization. Hosted by Jerry Dalfors, Principal, JD TechnologiesFor those wanting to attend, there is currently an early bird offer available; book by 28th February to save $300 off the conference price. Register at www.pharma-microbiology-usa.com/prcomPharmaceutical Microbiology USA is sponsored by Charles River and Rapid MicrobiosytemsFor sponsorship packages: Contact Alia Malick +44 (0) 207 827 6168 or e-mail amalick@smi-online.co.uk.For delegate enquiries: Contact Fateja Begum on +44 (0) 20 7827 6184 or emailfbegum@smi-online.co.ukFor media enquiries, contact Zoe Gale on +44 (0) 20 7827 6138 or zgale@smi-online.co.ukPharmaceutical Microbiology USA8 - 9 June 2017San Diego, California, USAwww.pharma-microbiology-usa.com/prcomContact e-mail: zgale@smi-online.co.ukContact tel: +44 (0) 207 827 6184#smimicrobiologyAbout SMi Group: Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world’s most forward thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk Click here to view the list of recent Press Releases from SMi Group


Interactive Training Session on Cleanrooms and Environmental Monitoring at Pharmaceutical Microbiology USA SMi Group presents the seventh in its series, Pharmaceutical Microbiology USA will take place in San Diego, on the 8th and 9th June 2017. San Diego, CA, March 01, 2017 --( Morgan Polen the Subject Matter Expert on Contamination Control from Microrite will be hosting the training session on 'Effects of cleanrooms and barrier systems on environmental monitoring data'. Recent warning letters show that manufacturers of aseptic products are receiving the most 483s; many are related to smoke studies. Smoke / Airflow Visualization tests are often performed by third party certifiers. However, per FDA guidance, dynamic in-situ air pattern analysis is more complex. These studies should be investigative and effective at identifying design flaws or airflow issues. They should be performed using the correct type of smoke, smoke density, and camera angles. Therefore this exclusive one hour interactive training session will cover: • Regulations and guidelines related to smoke studies • Types of smoke (and equipment) used for smoke studies-pros and cons • Execution of an investigative smoke study • Case studies with videos of bad airflows and barrier system flaws • Practical demonstration of smoke vs fog • Discussions on 483s related to smoke studies • Mistakes made during environmental monitoring in barriers with inadequate laminar flow that lead to excursions. Alongside hosting the extended training sessions, Microrite will be providing a presentation throughout the two day conference where they will be joined by GSK, Bimeda, Sanofi, Amgen, Excellent Pharma Consulting, Renaissance Pharmaceuticals, Takeda, Vericel Corporation, Roche, Merck and more. All of the speakers have been carefully handpicked to provide insightful presentations from industry experts who will share recent case studies and discuss the developing trends in the field of pharmaceutical microbiology. Running alongside the conference will be two pre-conference workshops held on the 7th June. Workshop A: Technologies for Monitoring Contamination Control and Case Studies on Contamination Control. Hosted by Jim Polarine Jr, Senior Technical Service Manager, STERIS Corporation and Andrew Bartko, Research Leader, Battelle Memorial Institute. Workshop B: Microbial Required Use for Terminal Sterilization. Hosted by Jerry Dalfors, Principal, JD Technologies For those wanting to attend, there is currently an early bird offer available; book by 31st March to save $200 off the conference price. Register at www.pharma-microbiology-usa.com/prcom Pharmaceutical Microbiology USA is sponsored by Charles River and Rapid Microbiosytems For sponsorship packages: Contact Alia Malick +44 (0) 207 827 6168 or e-mail amalick@smi-online.co.uk. For delegate enquiries: Contact Fateja Begum on +44 (0) 20 7827 6184 or email fbegum@smi-online.co.uk For media enquiries, contact Zoe Gale on +44 (0) 20 7827 6138 or zgale@smi-online.co.uk Pharmaceutical Microbiology USA 8 - 9 June 2017 San Diego, California, USA www.pharma-microbiology-usa.com/prcom Contact e-mail: zgale@smi-online.co.uk Contact tel: +44 (0) 207 827 6184 #smimicrobiology About SMi Group: Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world’s most forward thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk San Diego, CA, March 01, 2017 --( PR.com )-- The 2017 agenda will provide, 16 thought provoking presentations, 17 leading expert speakers, 2 pre-conference workshops and an extended interactive training session.Morgan Polen the Subject Matter Expert on Contamination Control from Microrite will be hosting the training session on 'Effects of cleanrooms and barrier systems on environmental monitoring data'.Recent warning letters show that manufacturers of aseptic products are receiving the most 483s; many are related to smoke studies. Smoke / Airflow Visualization tests are often performed by third party certifiers. However, per FDA guidance, dynamic in-situ air pattern analysis is more complex. These studies should be investigative and effective at identifying design flaws or airflow issues. They should be performed using the correct type of smoke, smoke density, and camera angles. Therefore this exclusive one hour interactive training session will cover:• Regulations and guidelines related to smoke studies• Types of smoke (and equipment) used for smoke studies-pros and cons• Execution of an investigative smoke study• Case studies with videos of bad airflows and barrier system flaws• Practical demonstration of smoke vs fog• Discussions on 483s related to smoke studies• Mistakes made during environmental monitoring in barriers with inadequate laminar flow that lead to excursions.Alongside hosting the extended training sessions, Microrite will be providing a presentation throughout the two day conference where they will be joined by GSK, Bimeda, Sanofi, Amgen, Excellent Pharma Consulting, Renaissance Pharmaceuticals, Takeda, Vericel Corporation, Roche, Merck and more. All of the speakers have been carefully handpicked to provide insightful presentations from industry experts who will share recent case studies and discuss the developing trends in the field of pharmaceutical microbiology.Running alongside the conference will be two pre-conference workshops held on the 7th June.Workshop A: Technologies for Monitoring Contamination Control and Case Studies on Contamination Control. Hosted by Jim Polarine Jr, Senior Technical Service Manager, STERIS Corporation and Andrew Bartko, Research Leader, Battelle Memorial Institute.Workshop B: Microbial Required Use for Terminal Sterilization. Hosted by Jerry Dalfors, Principal, JD TechnologiesFor those wanting to attend, there is currently an early bird offer available; book by 31st March to save $200 off the conference price. Register at www.pharma-microbiology-usa.com/prcomPharmaceutical Microbiology USA is sponsored by Charles River and Rapid MicrobiosytemsFor sponsorship packages: Contact Alia Malick +44 (0) 207 827 6168 or e-mail amalick@smi-online.co.uk.For delegate enquiries: Contact Fateja Begum on +44 (0) 20 7827 6184 or emailfbegum@smi-online.co.ukFor media enquiries, contact Zoe Gale on +44 (0) 20 7827 6138 or zgale@smi-online.co.ukPharmaceutical Microbiology USA8 - 9 June 2017San Diego, California, USAwww.pharma-microbiology-usa.com/prcomContact e-mail: zgale@smi-online.co.ukContact tel: +44 (0) 207 827 6184#smimicrobiologyAbout SMi Group: Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world’s most forward thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk Click here to view the list of recent Press Releases from SMi Group


Wiseguyreports.Com Adds “Hand Sanitizer Dispenser -Market Demand, Growth, Opportunities and analysis of Top Key Player Forecast to 2021” To Its Research Database This report studies sales (consumption) of Hand Sanitizer Dispenser in Global market, especially in United States, China, Europe, Japan, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering Market Segment by Regions, this report splits Global into several key Regions, with sales (consumption), revenue, market share and growth rate of Hand Sanitizer Dispenser in these regions, from 2011 to 2021 (forecast), like United States China Europe Japan Split by product Types, with sales, revenue, price and gross margin, market share and growth rate of each type, can be divided into Type I Type II Type III Split by applications, this report focuses on sales, market share and growth rate of Hand Sanitizer Dispenser in each application, can be divided into Application 1 Application 2 Application 3 Global Hand Sanitizer Dispenser Sales Market Report 2016 1 Hand Sanitizer Dispenser Overview 1.1 Product Overview and Scope of Hand Sanitizer Dispenser 1.2 Classification of Hand Sanitizer Dispenser 1.2.1 Type I 1.2.2 Type II 1.2.3 Type III 1.3 Application of Hand Sanitizer Dispenser 1.3.1 Application 1 1.3.2 Application 2 1.3.3 Application 3 1.4 Hand Sanitizer Dispenser Market by Regions 1.4.1 United States Status and Prospect (2011-2021) 1.4.2 China Status and Prospect (2011-2021) 1.4.3 Europe Status and Prospect (2011-2021) 1.4.4 Japan Status and Prospect (2011-2021) 1.5 Global Market Size (Value and Volume) of Hand Sanitizer Dispenser (2011-2021) 1.5.1 Global Hand Sanitizer Dispenser Sales and Growth Rate (2011-2021) 1.5.2 Global Hand Sanitizer Dispenser Revenue and Growth Rate (2011-2021) 7 Global Hand Sanitizer Dispenser Manufacturers Analysis 7.1 GOJO Industries 7.1.1 Company Basic Information, Manufacturing Base and Competitors 7.1.2 Hand Sanitizer Dispenser Product Type, Application and Specification 7.1.2.1 Type I 7.1.2.2 Type II 7.1.3 GOJO Industries Hand Sanitizer Dispenser Sales, Revenue, Price and Gross Margin (2011-2016) 7.1.4 Main Business/Business Overview 7.2 Symmetry 7.2.1 Company Basic Information, Manufacturing Base and Competitors 7.2.2 105 Product Type, Application and Specification 7.2.2.1 Type I 7.2.2.2 Type II 7.2.3 Symmetry Hand Sanitizer Dispenser Sales, Revenue, Price and Gross Margin (2011-2016) 7.2.4 Main Business/Business Overview 7.3 Proandre 7.3.1 Company Basic Information, Manufacturing Base and Competitors 7.3.2 121 Product Type, Application and Specification 7.3.2.1 Type I 7.3.2.2 Type II 7.3.3 Proandre Hand Sanitizer Dispenser Sales, Revenue, Price and Gross Margin (2011-2016) 7.3.4 Main Business/Business Overview 7.4 STERIS Corporation 7.4.1 Company Basic Information, Manufacturing Base and Competitors 7.4.2 Oct Product Type, Application and Specification 7.4.2.1 Type I 7.4.2.2 Type II 7.4.3 STERIS Corporation Hand Sanitizer Dispenser Sales, Revenue, Price and Gross Margin (2011-2016) 7.4.4 Main Business/Business Overview 7.5 The Dial Corporation 7.5.1 Company Basic Information, Manufacturing Base and Competitors 7.5.2 Product Type, Application and Specification 7.5.2.1 Type I 7.5.2.2 Type II 7.5.3 The Dial Corporation Hand Sanitizer Dispenser Sales, Revenue, Price and Gross Margin (2011-2016) 7.5.4 Main Business/Business Overview 7.6 INOPAK 7.6.1 Company Basic Information, Manufacturing Base and Competitors 7.6.2 Million USD Product Type, Application and Specification 7.6.2.1 Type I 7.6.2.2 Type II 7.6.3 INOPAK Hand Sanitizer Dispenser Sales, Revenue, Price and Gross Margin (2011-2016) 7.6.4 Main Business/Business Overview ...


Patent
STERIS Corporation | Date: 2016-08-25

An amperometric gas sensor for measuring the concentration of an analyte includes: a solid configured as an insulator without being contacted by the analyte and configured for diffusion of the analyte therethrough, the solid including a non-conductive polymer, the solid further configured to increase in electrical conductivity when in contact with the analyte; a working electrode positioned on and in contact with the solid; and a reference electrode positioned on and in contact with the solid, the reference electrode spaced apart and insulated from the working electrode without the solid being contacted by the analyte, the working electrode and the reference electrode configured to measure electrical conductivity of the solid when the solid is in contact with the analyte.


Reactive compositions are provided, having biocidal and chemical decontamination/neutralization properties, comprising a hygroscopic polymer and an active, which are useful in a variety of commercial, healthcare and military applications and a wide variety of contaminants, including without limitation chemical and biological warfare agents. The reactive compositions are renewable or rechargeable after use by exposure to an additional application of the active and do not require removal, disposal or replacement of the originally applied composition. Methods for preparing and applying the reactive compositions are disclosed.


Patent
STERIS Corporation | Date: 2011-05-25

A self contained unit and system for determining whether medical equipment or devices such as endoscopes, minimally invasive surgical instruments (MIS), etc., are blocked, or substantially free flowing, or are disconnected or leaking before they are subjected to cleaning and/or a disinfecting process that is either sequential or simultaneous. The apparatus has a manifold that generally receives predetermined amounts of a gas and/or liquid for dispensing to one and preferably a plurality of channels. Advantageously, the test apparatus of the present invention can be utilized as a stand-alone unit that is able to monitor the noted medical equipment or devices with regard to the flow of a gas and/or liquid therethrough such as large or small lumens and such flow can also be automatically verified by a system independent of human intervention. Alternatively, the test apparatus can be utilized as part of a comprehensive system in conjunction with other devices for testing, cleaning, and/or disinfecting.


Patent
STERIS Corporation | Date: 2014-09-30

The disclosed invention relates to an amperometric gas sensor for measuring the concentration of an analyte, comprising: a solid support; and a working electrode in contact with the solid support; wherein the analyte comprises a dopant which when in contact with the solid support increases the electrical conductivity of the solid support. A sterilization process employing the amperometric gas sensor is disclosed.


Patent
STERIS Corporation | Date: 2014-09-30

The disclosed invention relates to an amperometric gas sensor for measuring the concentration of an analyte, comprising: a solid support; and a working electrode in contact with the solid support; wherein the analyte comprises a dopant which when in contact with the solid support increases the electrical conductivity of the solid support. A sterilization process employing the amperometric gas sensor is disclosed.


Patent
STERIS Corporation | Date: 2013-02-26

The disclosed invention relates to an amperometric gas sensor for measuring the concentration of an analyte, comprising: a solid support; and a working electrode in contact with the solid support; wherein the analyte comprises a dopant which when in contact with the solid support increases the electrical conductivity of the solid support. A sterilization process employing the amperometric gas sensor is disclosed.

Loading STERIS Corporation collaborators
Loading STERIS Corporation collaborators